Advanced Search
LI Yanping, ZHOU Yajuan, WU Yuan, LI Ying, PI Guoliang, HE Hanping, TAN Wenyong. Theoretical Analysis of Optimal Dose-fractionation of Intensity-modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(02): 148-152. DOI: 10.3971/j.issn.1000-8578.2014.02.013
Citation: LI Yanping, ZHOU Yajuan, WU Yuan, LI Ying, PI Guoliang, HE Hanping, TAN Wenyong. Theoretical Analysis of Optimal Dose-fractionation of Intensity-modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(02): 148-152. DOI: 10.3971/j.issn.1000-8578.2014.02.013

Theoretical Analysis of Optimal Dose-fractionation of Intensity-modulated Radiotherapy in Head and Neck Squamous Cell Carcinoma

More Information
  • Received Date: May 07, 2013
  • Revised Date: July 17, 2013
  • Objective To analyze theoretically the optimal dose-fractionation of intensity-modulated radiotherapy in head and neck squamous cell carcinoma (HNSCC). Methods The common dosefractionation of 33 division, keeping the irradiation dose of 70 Gy, biological effect dose (BED) of 84Gy10 and prolong overall treatment time was applied to simulate different dose and time treatment, respectively. The linear-quadric function was used to calculate the tumor, early response (mucosal), late response BED and the tumor log10 cell kill with different fraction number and/or dose to fi nd out the optimal fractionation. Results With 33 fractions, the fraction dose and total irradiation dose varied from 2.12-2.30 Gy and 70.0-75.9 Gy respectively. The doses of tumor, mucosal and late effect BED were 69.6Gy-78.2Gy10, 55.5-64.1Gy10, and 119.4-129.5Gy3 respectively. The tumor log10 cell kill was 10.6-11.9. While keeping the physical irradiation dose of 70 Gy or BED of 84Gy10, the fraction dose ranged from 2.20-2.80 Gy with 25-35 fractions and the total treatment day (TTD) was 32-46. The doses of tumor, early and late response BED were 67.5-82.3Gy10, 53.1-69.8Gy10, and 113.5-119.8Gy3 respectively and the tumor log10 cell kill was 10.3-12.5. Taking the tumor, early and late response BED and tumor cell log10 kill into comprehensive consideration, the regimen with 30 daily IMRT fractions can balance the tumor control and radiation-related toxicity well. For every single prolonged day, the tumor BED decreased 1.4% (0.8Gy10) and the tumor log10 cell kill did 0.1. Conclusion The optimal dose-fraction in IMRT of HNSCC is theatrically 30 daily fractions in six weeks. And the tumor BED will decrease with the prolonged overall treatment days.
  • [1]
    Lee AW,Lin JC,Ng WT.Current management of nasopharyngeal cancer[J].Semin Radiat Oncol,2012,22(3):233-44.
    [2]
    Lee AW,Ng WT,Chan YH,et al.The battle against nasopharyngeal cancer[J].Radiother Oncol,2012,104(3):272-8.
    [3]
    Fowler JF.Practical time-dose evaluations, or how to stop worrying and learn to love linear quadratics[M]. In: Levitt SH, Purdy JA,Perez CA. Technical Basis of Radiation Therapy. Berlin Heidelberg: Springer-Verlag,2012:3-50.
    [4]
    Fowler JF. 21 years of biologically effective dose[J]. Br J Radiol, 20 10,83(991):554-68.
    [5]
    Fowler JF.Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling[J].Clin Oncol (R Coll Radiol),2007,19(1):8-22.
    [6]
    Drr W,Hamilton CS,Boyd T,et al.Radiation-induced changes in cellularity and proliferation in human oral mucosa[J]. Int J Radiat Oncol Biol Phys,2002,52(4):911-7.
    [7]
    Ho KF,Fowler JF,Sykes AJ,et al.IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation diffi cult[J].Acta Oncol,2009,48(3):431-9.
  • Related Articles

    [1]XIAO Jincheng, GUO Leiming, KANG Xinxin, BAI Qiwen, ZHANG Junling, LI Jing. Comparison of Efficiency and Safety Between Radiofrequency Ablation and Stereotactic Body Radiotherapy on Primary Small Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 831-835. DOI: 10.3971/j.issn.1000-8578.2017.17.0613
    [2]LU Sicong, LU Haiming, LIU Lei, JIANG Shuiming, ZHANG Qishun. Emergency Transcatheter Arterial Embolization Combined with Two-stage Liver Resection for Spontaneous Ruptured Hepatocellular Carcinoma: A Systematic Review[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 997-1000. DOI: 10.3971/j.issn.1000-8578.2015.10.010
    [3]LU Jingning, YANG Hong, PENG Minhao, XIAO Kaiyin, PENG Tao, PENG Jinbo. Percutaneous Ultrasound-guided Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in Hepatic Dome[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 493-497. DOI: 10.3971/j.issn.1000-8578.2015.05.016
    [4]Shen Xinying, Zhang Yanfang, Kong Jian, Dou Yongchong, Li Yong, Cai Jinzhong, He Fan, Chen Xudong. Therapeutic Value of Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma with Arterioportal Shunts[J]. Cancer Research on Prevention and Treatment, 2012, 39(09): 1120-1124. DOI: 10.3971/j.issn.1000-8578.2012.09.016
    [5]PENG Qi-rong, XIAO Bi, ZHANG Jian, CHENG Tao, CHEN Guo-qiang. Percutaneous Microwave Coagultion Therapy Influence on Hepatofibrosis of Primary Hepatocellular Carcinoma Serum[J]. Cancer Research on Prevention and Treatment, 2011, 38(03): 322-323. DOI: 10.3971/j.issn.1000-8578.2011.03.022
    [6]HUANG Jin-qiu, PENG Min-hao, ZOU Quan-qing, YANG Ding-hua, CHEN Bin, XIAO Kai-yin. Cox Model Analysis of Prognostic Factors after Radical Hepatectomy for Primary Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(02): 137-139. DOI: 10.3971/j.issn.1000-8578.2009.02.015
    [8]MA Guoan. RFA Combined with TACE for Primary Hepatic Carcinoma[J]. Cancer Research on Prevention and Treatment, 2006, 33(12): 905-907. DOI: 10.3971/j.issn.1000-8578.3352
    [9]SONG Bin, WANG Wei-xing, ZHANG Wen, et al. Effect of the different combined therapy methods of transcatheter arterial chemoembolization (TACE) and percutaneous radio-frequency ablation(RF) on the elder patients with unresectable hepatocellular carcinoma(HCC)[J]. Cancer Research on Prevention and Treatment, 2003, 30(06): 496-497. DOI: 10.3971/j.issn.1000-8578.2920
    [10]Jiang Xiao-Qing, Yin Guang-fu, Su Ka-qing, Wang Hao. Study on apoptosis of hepatocellular carcinoma cells after intrahepatic arterial angiotensin Ⅱ infusion induced hypertension and chemoembolization (IHCE )[J]. Cancer Research on Prevention and Treatment, 1996, 23(6): 350-351.

Catalog

    Article views (1507) PDF downloads (1004) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return